Aktuellt
SENASTE
Redeye provides an initial take on Sedana Medical’s Q4 results, and we are optimistic about the sales coming in 12% above our forecast and in line with our estimates for adjusted EBITDA. We will return shortly with a more in-depth take on the report and fair value range changes.
LÄS MER
